Novan, Inc. (NOVN): Price and Financial Metrics

Novan, Inc. (NOVN): $0.09

0.03 (-24.84%)

POWR Rating

Component Grades








NOVN Price/Volume Stats

Current price $0.09 52-week high $3.33
Prev. close $0.13 52-week low $0.08
Day low $0.08 Volume 7,190,000
Day high $0.14 Avg. volume 602,421
50-day MA $0.73 Dividend yield N/A
200-day MA $1.13 Market Cap 2.64M

NOVN Stock Price Chart Interactive Chart >


  • NOVN scores best on the Growth dimension, with a Growth rank ahead of 66.89% of US stocks.
  • NOVN's strongest trending metric is Stability; it's been moving up over the last 177 days.
  • NOVN ranks lowest in Quality; there it ranks in the 6th percentile.

NOVN Stock Summary

  • NOVAN INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 1.89% of US listed stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 17.69 for NOVAN INC; that's greater than it is for 97.12% of US stocks.
  • As for revenue growth, note that NOVN's revenue has grown 512.74% over the past 12 months; that beats the revenue growth of 98.48% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to NOVAN INC, a group of peers worth examining would be SCYX, SOFO, SPCB, MOTS, and AVGR.
  • Visit NOVN's SEC page to see the company's official filings. To visit the company's web site, go to

NOVN Valuation Summary

  • NOVN's price/sales ratio is 0.5; this is 89.58% lower than that of the median Healthcare stock.
  • Over the past 82 months, NOVN's EV/EBIT ratio has gone up 5.1.

Below are key valuation metrics over time for NOVN.

Stock Date P/S P/B P/E EV/EBIT
NOVN 2023-06-28 0.5 -4.6 -0.4 -0.4
NOVN 2023-06-27 0.5 -4.0 -0.4 -0.3
NOVN 2023-06-26 0.5 -4.1 -0.4 -0.3
NOVN 2023-06-23 0.5 -4.2 -0.4 -0.3
NOVN 2023-06-22 0.6 -5.2 -0.5 -0.4
NOVN 2023-06-21 0.6 -5.4 -0.5 -0.5

NOVN Growth Metrics

    Its 5 year price growth rate is now at -93.03%.
  • Its 5 year net income to common stockholders growth rate is now at 50.55%.
  • Its 4 year cash and equivalents growth rate is now at -36.49%.
NOVN's revenue has moved up $11,178,000 over the prior 52 months.

The table below shows NOVN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 13.856 -28.515 -36.521
2022-06-30 9.478 -24.132 -36.975
2022-03-31 4.067 -15.41 -34.12
2021-12-31 2.958 -24.777 -29.692
2021-09-30 3.372 -25.228 -28.094
2021-06-30 3.952 -28.259 -30.015

NOVN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NOVN has a Quality Grade of D, ranking ahead of 5.71% of graded US stocks.
  • NOVN's asset turnover comes in at 0.072 -- ranking 285th of 682 Pharmaceutical Products stocks.
  • VBIV, RIOT, and ASRT are the stocks whose asset turnover ratios are most correlated with NOVN.

The table below shows NOVN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.072 1 -8.838
2021-03-31 0.097 1 -7.579
2020-12-31 0.111 1 -7.267
2020-09-30 0.132 1 -3.706
2020-06-30 0.140 1 -2.821
2020-03-31 0.134 1 -5.195

NOVN Price Target

For more insight on analysts targets of NOVN, see our NOVN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $3.00 Average Broker Recommendation 1.5 (Moderate Buy)

Novan, Inc. (NOVN) Company Bio

Novan, Inc. focuses on the development and commercialization of nitric oxide-based therapies in dermatology. Its lead product candidate is SB204, a cosmetically elegant topical gel that targets multiple mechanisms of action for the treatment of acne vulgaris. The company was founded in 2006 and is based in Durham, North Carolina.

NOVN Latest News Stream

Event/Time News Detail
Loading, please wait...

NOVN Latest Social Stream

Loading social stream, please wait...

View Full NOVN Social Stream

Latest NOVN News From Around the Web

Below are the latest news stories about NOVAN INC that investors may wish to consider to help them evaluate NOVN as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today!

William White on InvestorPlace | June 29, 2023

Investors Holding Back On Novan, Inc. (NASDAQ:NOVN)

Novan, Inc.'s ( NASDAQ:NOVN ) price-to-sales (or "P/S") ratio of 1.1x might make it look like a buy right now compared...

Yahoo | June 7, 2023

Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders

DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2023 Annual Meeting of Stockholders (“ASM”) being held on Tuesday, June 6, 2023 at 9:30 a.m. Eastern Time in a virtual format. The Company also announced that its Chairman, President and CEO, Paula Brown Stafford, will provide a corporate update on the Company after the conclusion of the ASM, including the Company’s current

Yahoo | June 5, 2023

Novan Focuses Strategic Direction and Announces Restructuring

– Company directing resources on the potential approval of berdazimer gel, 10.3% (SB206) for molluscum contagiosum – – Process to explore a sale or out-license of commercial assets or other business transaction continues – – Continued progress toward PDUFA goal date of January 5, 2024, for berdazimer gel, 10.3% – DURHAM, N.C., May 31, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that following an evaluation of its commercial and developmental st

Yahoo | May 31, 2023

NOVN: Counting Down to PDUFA

By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT 1Q:23 Financial and Operational Results On May 15th, 2023, Novan Inc. (NASDAQ:NOVN) reported 1Q:23 financial and operational results in a press release and in the filing of Form 10-Q . A conference call and webcast were subsequently held to update investors on recent developments. The call highlighted the performance of the

Yahoo | May 16, 2023

Read More 'NOVN' Stories Here

NOVN Price Returns

1-mo N/A
3-mo -79.07%
6-mo -93.57%
1-year -95.19%
3-year -98.13%
5-year -99.68%
YTD -93.84%
2022 -64.99%
2021 -48.71%
2020 -74.27%
2019 280.72%
2018 -80.33%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!